Reduction of blood pressure variability by combination therapy in spontaneously hypertensive rats

Journal of Hypertension

Volumn 25, Issue 11, 2007, Pages 2334-2344

  Xie, He Hui ^a   Shen, Fu Ming ^a   Xu, Li Ping ^a   Han, Ping ^a   Miao, Chao Yu ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Blood pressure; Blood pressure variability; Combination; End organ damage; Hypertension

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; ENALAPRIL; HYDROCHLOROTHIAZIDE; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE VARIABILITY; CONTROLLED STUDY; DIET; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMORAL VEIN; HYPERTENSION; MALE; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; RAT;

EID: 35148851066     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282ef547f     Document Type: Article

References (23)

1. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358:1305-1315.
2. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-h blood pressure mean and variability to severity of target organ damage in hypertension. J Hypertens 1987; 5:93-98.
3. Parati G, Valentini M. Prognostic relevance of blood pressure variability. Hypertension 2006; 47:137-138.
4. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, et al., ELSA Investigators. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001; 19:1981-1989.
5. Su DF, Miao CY. Reduction of blood pressure variability: a new strategy for the treatment of hypertension. Trends Pharmacol Sci 2005; 26:388-390.
6. Miao CY, Su DF. The importance of blood pressure variability in rat aortic and left ventricular hypertrophy produced by sinoaortic denervation. J Hypertens 2002; 20:1865-1872.
7. Miao CY, Yuan WJ, Su DF. Comparative study of sinoaortic-denervated rats and spontaneously hypertensive rats. Am J Hypertens 2003; 16:585-591.
8. Du WM, Miao CY, Liu JG, Shen FM, Yang XQ, Su DF. Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats. J Cardiovasc Pharmacol 2003; 41:233-239.
9. Miao CY, Xie HH, Yu H, Chu ZX, Su DF. Ketanserin stabilizes blood pressure in conscious spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2003; 30:189-193.
10. Xie HH, Miao CY, Liu JG, Su DF. Effects of long-term treatment with candesartan on organ damages in sinoaortic denervated rats. J Cardiovasc Pharmacol 2003; 41:325-331.
11. Miao CY, Xie HH, Zhan LS, Su DF. Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens 2006; 24:1137-1146.
12. Liu JG, Xu LP, Chu ZX, Miao CY, Su DF. Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats. J Hypertens 2003; 21:1961-1967.
13. Hayakawa H, Raij L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension 1997; 29:235-241.
14. Kimula K, Tojo A, Matsuoka H, Sugimoto T. Renal arteriolar diameters in spontaneously hypertensive rats: vascular cast study. Hypertension 1991; 18:101-110.
15. Mensah GA, Croft JB, Giles WH. The heart, kidney, and brain as target organs in hypertension. Cardiol Clin 2002; 20:225-247.
16. Mancia G, Omboni S, Parati G. The importance of blood pressure variability in hypertension. Blood Press Monit 2000; 5 (Suppl 1):S9-S15.
17. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michmata M, Matsubara M, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36:901-906.
18. Sander D, Kukla C, Klingelhofer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000; 102:1536-1541.
19. Parati G, Lantelme P. Blood pressure variability, target organ damage and cardiovascular events. J Hypertens 2002; 20:1725-1729.
20. Zakopoulos NA, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E, et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005; 45:505-512.
21. Kario K. Morning surge and variability in blood pressure: a new therapeutic target? Hypertension 2005; 45:485-486.
22. Sasaki S, Yoneda Y, Fujita H, Uchida A, Takenaka K, Takesako T, et al. Association of blood pressure variability with induction of atherosclerosis in cholesterol-fed rats. Am J Hypertens 1994; 7:453-459.
23. Hata Y, Kimura Y, Muratani H, Fukiyama K, Kawano Y, Ashida T, et al. Office blood pressure variability as a predictor of brain infarction in elderly hypertensive patients. Hypertens Res 2000; 23:553-560.